{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T21:38:57Z","timestamp":1788212337312,"version":"build-2803163510"},"reference-count":31,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T00:00:00Z","timestamp":1774742400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T00:00:00Z","timestamp":1774742400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Thoracic Cancer"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Kirsten rat sarcoma viral oncogene homolog (KRAS) is the most commonly mutated oncogene in solid tumors, detected in up to 30% of lung adenocarcinomas. This study aimed to address gaps in the literature by analyzing KRAS mutations (KRASM) in a large Australian population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 3982 patients with metastatic nonsquamous nonsmall cell lung cancer diagnosed via public hospitals were retrospectively analyzed from January 1, 2014 to December 31, 2023. Records were reviewed for evidence of KRASM testing, KRAS results, biopsy type, and programmed death\u2010ligand 1 (PD\u2010L1) status. KRASM testing rates were also compared to that of other commonly tested oncogenic mutations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>KRASM testing was performed in 52.9% of eligible patients, improving from 1.9% in 2014 to 86.3% in 2023. KRASM was identified in 830 patients (39.4% of KRASM tested patients, 20.8% overall). The most common KRASM seen was 12th codon substitution of KRAS glycine to cysteine (G12C) followed by substitutions of glycine to valine (G12V) and glycine to aspartate (G12D). Patients harboring KRASM were significantly more likely to have smoked, be female, and have higher PD\u2010L1 expression than their KRAS wild type (wt) counterparts. All\u2010cause survival was higher at the 1\u2010year (43.9% vs. 35.3%) and 5\u2010year (12.4% vs. 8.9%) marks in KRAS wt patients compared to KRAS mt.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study is the largest longitudinal analysis of KRASM testing conducted in Australia, with significant improvement in testing rates seen over the time period. Rates of KRASM and characteristics of Australian KRAS mt patients correspond with published literature.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/1759-7714.70274","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T04:40:44Z","timestamp":1774845644000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Kirsten Rat Sarcoma Viral Oncogene Homolog (\n                    <scp>KRAS<\/scp>\n                    ) Mutation Testing Trends, Prevalence, and Outcomes in Metastatic, Non\u2010Squamous Non\u2010Small Cell Lung Cancer (Non\u2010\n                    <scp>SQ NSCLC<\/scp>\n                    ) Patients in Queensland, Australia From 2014\u20132023"],"prefix":"10.1111","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2941-4405","authenticated-orcid":false,"given":"Navin","family":"Niranjan","sequence":"first","affiliation":[{"name":"Gold Coast University Hospital  Southport Queensland Australia"},{"name":"School of Medicine and Dentistry Griffith University  Southport Queensland Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7211-4256","authenticated-orcid":false,"given":"Tracey","family":"Guan","sequence":"additional","affiliation":[{"name":"Department of Health, Metro South Hospital and Health Service Cancer Alliance Queensland  Woolloongabba Queensland Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Niranjan","sequence":"additional","affiliation":[{"name":"Gold Coast University Hospital  Southport Queensland Australia"},{"name":"School of Medicine and Dentistry Griffith University  Southport Queensland Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atefeh","family":"Taherian Fard","sequence":"additional","affiliation":[{"name":"Department of Health, Metro South Hospital and Health Service Cancer Alliance Queensland  Woolloongabba Queensland Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2721-9083","authenticated-orcid":false,"given":"Danny R.","family":"Youlden","sequence":"additional","affiliation":[{"name":"Department of Health, Metro South Hospital and Health Service Cancer Alliance Queensland  Woolloongabba Queensland Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Mason","sequence":"additional","affiliation":[{"name":"Gold Coast University Hospital  Southport Queensland Australia"},{"name":"School of Medicine and Dentistry Griffith University  Southport Queensland Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan A.","family":"Chan","sequence":"additional","affiliation":[{"name":"Adem Crosby Cancer Centre Sunshine Coast University Hospital  Birtinya Queensland Australia"},{"name":"School of Medicine and Dentistry Griffith University  Birtinya Queensland Australia"},{"name":"Centre for Bioinnovation University of the Sunshine Coast  Sippy Downs Queensland Australia"},{"name":"Department of Health, Metro South Hospital and Health Service Queensland Cancer Control Safety and Quality Partnership, Lung Cancer Subcommittee  Woolloongabba Queensland Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasotha","family":"Sanmugarajah","sequence":"additional","affiliation":[{"name":"Gold Coast University Hospital  Southport Queensland Australia"},{"name":"School of Medicine and Dentistry Griffith University  Southport Queensland Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,3,29]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12020709"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2023.107293"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-017-2005-z"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctarc.2020.100200"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2020.09.005"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000002529"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2103695"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2204619"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2024.06.001"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2025.05.016"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-24-0027"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.4c02313"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2025.108421"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2023.02.021"},{"key":"e_1_2_10_16_1","unstructured":"Medical Services Advisory Committee \u201cMSAC Application 1407: EGFR Mutation Testing to Determine Eligibility for Access to PBS Subsidised AZD9291 Therapy in Patients with Locally Advanced or Metastatic EGFRm NSCLC (Final Protocol) \u201d2015 https:\/\/www.msac.gov.au\/sites\/default\/files\/documents\/1407\u2010EGFRMutationTesting\u2010FinalProtocol.pdf."},{"key":"e_1_2_10_17_1","unstructured":"Department of Health Disability and Ageing \u201cModified Monash Model \u201d2025 accessed November 21 2025 https:\/\/www.health.gov.au\/topics\/rural\u2010health\u2010workforce\/classifications\/mmm."},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1159\/000521288"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.e13505"},{"key":"e_1_2_10_20_1","unstructured":"Department of Health Disability and Ageing \u201cMedicine Status Website\u2014Sotorasib \u201d2026 accessed January 6 2026 https:\/\/www.pbs.gov.au\/medicinestatus\/document\/691.html."},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathol.2025.02.001"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1071\/PU24004"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2022.03.015"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2020.06.030"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyaf153"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cllc.2023.05.002"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.103473"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199008303230902"},{"key":"e_1_2_10_29_1","first-page":"1","article-title":"Overcoming KRAS\u2010Mutant Lung Cancer","volume":"42","author":"Luo J.","year":"2022","journal-title":"American Society of Clinical Oncology Educational Book"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-10778-6"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.TPS8649"},{"issue":"16","key":"e_1_2_10_32_1","article-title":"Krascendo 2: A Phase III Study of Divarasib and Pembrolizumab vs Pembrolizumab and Chemotherapy in Patients With Previously Untreated, Advanced or Metastatic, KRAS G12C\u2010Mutated Non\u2010Small Cell Lung Cancer (NSCLC)","volume":"43","author":"Skoulidis F.","year":"2025","journal-title":"Journal of Clinical Oncology"}],"container-title":["Thoracic Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1759-7714.70274","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/1759-7714.70274","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1759-7714.70274","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T02:36:23Z","timestamp":1776220583000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1759-7714.70274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,29]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1111\/1759-7714.70274"],"URL":"https:\/\/doi.org\/10.1111\/1759-7714.70274","archive":["Portico"],"relation":{},"ISSN":["1759-7706","1759-7714"],"issn-type":[{"value":"1759-7706","type":"print"},{"value":"1759-7714","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,29]]},"assertion":[{"value":"2026-02-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70274"}}